Koert Gerzon - Concepedia

Concepedia

Author

Koert Gerzon

Eli Lilly (United States)

Also Known As

Gerzon, Koert, K Gerzon, K. GERZON, K. Gerzon, Koert Gerzon, Koert. Gerzon

57

Publications

1.9K

Citations

25

H-Index

70

Concepts

All Affiliations

Eli Lilly (United States)Indiana University – Purdue University Indianapolis Indiana University School of Medicine University of Nevada, Reno Université de Sherbrooke

KG

About

Koert Gerzon is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	25	1.3K
2	Biochemistry	19	25	1.3K
3	Natural Sciences	14	17	868
4	Engineering	3	3	254
5	Biomolecular Engineering	2	2	84

Koert Gerzon

×

39

Publications

1.9K

Citations

25

H-Index

	Year	Citations
Erythromycin. I. Properties and Degradation Studies<sup>1</sup> Edwin H. Flynn, Max V. Sigal, Paul F. Wiley, Journal of the American Chemical Society EngineeringChemical AnalysisAltmetric Attention ScoreOrganic ChemistryAntimicrobial Chemotherapy	1954	204
Erythromycin. X.<sup>1</sup> Structure of Erythromycin Paul F. Wiley, Koert Gerzon, Edwin H. Flynn, Journal of the American Chemical Society Pharmaceutical ScienceAltmetric Attention ScoreAntimicrobial ChemotherapyMedicinal ChemistryProtein X-ray Crystallography	1957	151
The Adamantyl Group in Medicinal Agents. I. Hypoglycemic N-Arylsulfonyl-N'-adamantylureas Koert Gerzon, Eriks V. Krumkalns, Richard L. Brindle, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryPharmaceutical ScienceBioorganic ChemistryBiochemistry	1963	140
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetyl vinblastine amide (vindesine) sulfate Charles J. Barnett, George J. Cullinan, Koert Gerzon, Journal of Medicinal Chemistry	1978	138
BIOCHEMISTRY AND BIOLOGICAL EFFECTS OF THE PYRAZOFURINS<sup>*</sup> (PYRAZOMYCINS): INITIAL CLINICAL TRIAL Gerald E. Gutowski, Martin Sweeney, Donald C. DeLong, Annals of the New York Academy of Sciences AntibioticsBiochemistryInitial Clinical TrialMedicineAntimicrobial Chemotherapy	1975	109
The Adamantyl Group in Medicinal Agents. III. Nucleoside 5′-Adamantoates. The Adamantoyl Function as a Protecting Group Koert Gerzon, Don Kau Journal of Medicinal Chemistry Preclinical TherapeuticsPharmaceutical ScienceAltmetric Attention ScoreOrganic ChemistryPharmacotherapy	1967	75
Adamantyloxycarbonyl, a New Blocking Group. Preparation of 1-Adamantyl Chloroformate<sup>1</sup> Walter Haas, Eriks V. Krumkalns, Koert Gerzon Journal of the American Chemical Society BiochemistryNatural SciencesAltmetric Attention ScoreOrganic ChemistrySocial Media Presence	1966	62
The Adamantyl Group in Medicinal Agents. II. Anabolic Steroid 17β-Adamantoates Richard T. Rapala, Russell J. Kraay, Koert Gerzon Journal of Medicinal Chemistry Preclinical TherapeuticsPharmaceutical ScienceAltmetric Attention ScorePharmacotherapyPre-clinical Pharmacology	1965	60
In Vitro Antiviral Activity of Mycophenolic Acid and Its Reversal by Guanine-Type Compounds J. C. Cline, Janet D. Nelson, Koert Gerzon, Applied Microbiology	1969	58
Structure-activity relationships of dimeric Catharanthus alkaloids. 2. Experimental antitumor activities of N-substituted deacetylvinblastine amide (vindesine) sulfates R. Conrad, George J. Cullinan, Koert Gerzon, Journal of Medicinal Chemistry Chemical BiologyPharmaceutical ChemistryMedicinal ChemistryAnti-cancer AgentB16 Melanoma	1979	57

Page 1